107 related articles for article (PubMed ID: 18171381)
1. Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
O'Connor MB; Murphy E; Phelan MJ; Regan MJ
Eur J Neurol; 2008 Jan; 15(1):e1. PubMed ID: 18171381
[No Abstract] [Full Text] [Related]
2. Focus on therapy of primary stabbing headache.
Ferrante E; Rossi P; Tassorelli C; Lisotto C; Nappi G
J Headache Pain; 2010 Apr; 11(2):157-60. PubMed ID: 20119679
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
Zhang S; Zhang Y; Liu P; Zhang W; Ma JL; Wang J
Clin Rheumatol; 2016 Jan; 35(1):151-8. PubMed ID: 26099603
[TBL] [Abstract][Full Text] [Related]
4. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
5. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.
Di Leo E; Aloia AM; Nettis E; Cardinale F; Foti C; Distaso M; Ferrannini A; Vacca A
Int J Immunopathol Pharmacol; 2009; 22(4):1131-4. PubMed ID: 20074479
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
[TBL] [Abstract][Full Text] [Related]
7. [Etoricoxib (Arcoxia)].
Leclercq P; Malaise MG
Rev Med Liege; 2004 May; 59(5):345-9. PubMed ID: 15270001
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache.
Drescher MJ; Wimpfheimer Z; Abu Khalef S; Gammaitoni A; Shehadeh N; Torgovicky R
Headache; 2012 Apr; 52(4):573-81. PubMed ID: 21848948
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
Andersohn F; Schade R; Suissa S; Garbe E
Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
[TBL] [Abstract][Full Text] [Related]
10. Nummular headache dramatically responsive to indomethacin.
Baldacci F; Nuti A; Lucetti C; Borelli P; Bonuccelli U
Cephalalgia; 2010 Sep; 30(9):1151-2. PubMed ID: 20713570
[No Abstract] [Full Text] [Related]
11. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
12. A case report on toxic epidermal necrolysis with etoricoxib.
Kameshwari JS; Devde R
Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache.
Drescher MJ; Alpert EA; Zalut T; Torgovicky R; Wimpfheimer Z
Headache; 2010 Sep; 50(8):1328-34. PubMed ID: 20039959
[TBL] [Abstract][Full Text] [Related]
14. Hemicrania continua unresponsive or partially responsive to indomethacin: does it exist? A diagnostic and therapeutic dilemma.
Prakash S; Shah ND; Bhanvadia RJ
J Headache Pain; 2009 Feb; 10(1):59-63. PubMed ID: 19096758
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin-responsive headache syndromes.
Dodick DW
Curr Pain Headache Rep; 2004 Feb; 8(1):19-26. PubMed ID: 14731379
[TBL] [Abstract][Full Text] [Related]
16. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Cannon CP; Curtis SP; Bolognese JA; Laine L;
Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
[TBL] [Abstract][Full Text] [Related]
18. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
19. Hypnic headache: a review of 2012 publications.
Patel S
Curr Pain Headache Rep; 2013 Jul; 17(7):346. PubMed ID: 23728805
[TBL] [Abstract][Full Text] [Related]
20. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor.
Farag M; Bahra A
Clin Neurol Neurosurg; 2023 Apr; 227():107646. PubMed ID: 36893522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]